Share Price and Basic Stock Data
Last Updated: January 17, 2026, 6:49 am
| PEG Ratio | 45.35 |
|---|
Analyst Insight & Comprehensive Analysis
AI Stock Ranker – Real-Time Fundamental Strength Score
Business Overview and Revenue Trends
Expleo Solutions Ltd, operating in the IT Consulting & Software industry, reported a market capitalization of ₹1,456 Cr and a share price of ₹938. The company has demonstrated consistent revenue growth, with total sales rising from ₹743 Cr in FY 2022 to ₹903 Cr in FY 2023. The trailing twelve months (TTM) revenue stood at ₹1,056 Cr, indicating a robust trajectory. Quarterly sales data reveals a steady increase, with revenues recorded at ₹220 Cr in September 2022, escalating to ₹234 Cr by September 2023, and projected to reach ₹259 Cr by September 2024. This growth is indicative of strong demand for IT consulting services, reflecting broader industry trends that favor digital transformation initiatives. The company’s operating profit margin (OPM) fluctuated, peaking at 30% in December 2022 before settling at 17% in the most recent period, suggesting some operational pressures but still above sector averages.
Profitability and Efficiency Metrics
Expleo’s profitability metrics reveal a solid performance, with a P/E ratio of 14.0 and a return on equity (ROE) of 16.3%. The net profit for FY 2023 was reported at ₹134 Cr, growing from ₹68 Cr in FY 2022. The operating profit for the last fiscal year stood at ₹200 Cr, providing a healthy operating leverage. However, the operating profit margin has seen fluctuations, with a high of 30% in December 2022, which has since declined, reflecting possible cost pressures. The interest coverage ratio (ICR) is notably high at 54.75x, indicating strong earnings relative to interest obligations, thus showcasing financial stability. Furthermore, the cash conversion cycle (CCC) is reported at 79 days, which is competitive and suggests effective working capital management, although it is essential to monitor for any upward trends that could indicate inefficiencies.
Balance Sheet Strength and Financial Ratios
Expleo Solutions maintains a robust balance sheet, with total assets reported at ₹916 Cr against total liabilities of ₹831 Cr, resulting in a healthy equity position. The company has reserves amounting to ₹688 Cr and minimal borrowings of ₹20 Cr, which underscores a conservative financing strategy. The debt-to-equity ratio remains low, indicating less reliance on external debt, which is favorable in a volatile market. The return on capital employed (ROCE) is reported at 21.5%, reflecting effective utilization of capital to generate profits. Additionally, the company’s price-to-book value (P/BV) ratio stands at 1.94x, suggesting that the stock is fairly valued when compared to its book value. However, as profitability margins fluctuate, it is crucial for the company to maintain its operational efficiency to sustain its financial health in the long term.
Shareholding Pattern and Investor Confidence
The shareholding structure of Expleo Solutions indicates substantial promoter confidence, with promoters holding 71.05% of the equity as of September 2023. This level of ownership can be interpreted as a strong alignment of interests between the management and shareholders. Foreign institutional investors (FIIs) hold a marginal 0.13%, while domestic institutional investors (DIIs) account for 0.84%, suggesting a limited institutional interest in the stock. The public shareholding stands at 28.00%, with the total number of shareholders increasing to 29,017, reflecting growing retail investor participation. This pattern may enhance liquidity in the stock, although the low institutional stake could indicate potential volatility in price movements. The increasing number of shareholders, particularly in the retail segment, could reflect positive sentiment towards the company’s growth prospects.
Outlook, Risks, and Final Insight
Looking ahead, Expleo Solutions is well-positioned to capitalize on the ongoing digital transformation trends within the IT sector. However, potential risks include fluctuating profit margins and operational challenges that may arise from rising costs or competitive pressures. The company’s ability to maintain its OPM and efficiently manage its operational expenses will be critical. Additionally, with a high dependence on domestic market dynamics, any economic downturn could pose risks to revenue growth. On the positive side, the strong balance sheet and robust cash flow generation provide a buffer against short-term challenges. If the company can enhance its operational efficiency and attract more institutional investors, it could see improved stock performance. Conversely, failure to address cost pressures or sustain profit margins may hinder its growth trajectory.
Source: Getaka Fundamental Analysis | Generated using proprietary financial data.
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Visesh Infotecnics Ltd | 125 Cr. | 0.33 | / | 1.11 | 0.00 % | 2.21 % | 2.23 % | 1.00 | |
| Mudunuru Ltd | 65.2 Cr. | 20.6 | 21.0/4.43 | 0.20 | 0.00 % | 27.0 % | 90.7 % | 2.00 | |
| Naapbooks Ltd | 131 Cr. | 122 | 194/99.8 | 20.1 | 36.4 | 0.00 % | 23.6 % | 17.1 % | 10.0 |
| IB Infotech Enterprises Ltd | 39.5 Cr. | 308 | 314/140 | 28.2 | 26.7 | 0.32 % | 38.5 % | 35.4 % | 10.0 |
| Hit Kit Global Solutions Ltd | 5.77 Cr. | 1.07 | 1.73/0.91 | 2.47 | 0.00 % | 2.14 % | 2.15 % | 2.00 | |
| Industry Average | 20,888.83 Cr | 547.66 | 83.43 | 123.78 | 0.57% | 14.88% | 20.92% | 6.84 |
Quarterly Result
| Metric | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 220 | 240 | 231 | 225 | 234 | 250 | 255 | 252 | 259 | 258 | 256 | 260 | 283 |
| Expenses | 178 | 168 | 188 | 192 | 200 | 212 | 221 | 213 | 217 | 219 | 216 | 230 | 236 |
| Operating Profit | 42 | 72 | 43 | 33 | 34 | 38 | 34 | 39 | 42 | 39 | 40 | 30 | 47 |
| OPM % | 19% | 30% | 19% | 15% | 14% | 15% | 13% | 15% | 16% | 15% | 16% | 11% | 17% |
| Other Income | 1 | 13 | 4 | 2 | 2 | 11 | 2 | 2 | 13 | 3 | 5 | 7 | 13 |
| Interest | 0 | 1 | 0 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 | 1 |
| Depreciation | 7 | 7 | 7 | 8 | 8 | 8 | 9 | 9 | 10 | 12 | 8 | 8 | 7 |
| Profit before tax | 36 | 77 | 39 | 26 | 27 | 41 | 26 | 31 | 44 | 28 | 36 | 28 | 51 |
| Tax % | 33% | 28% | 26% | 22% | 24% | 16% | 40% | 23% | 20% | 30% | 32% | 28% | 23% |
| Net Profit | 24 | 55 | 29 | 20 | 21 | 34 | 16 | 24 | 35 | 20 | 24 | 20 | 40 |
| EPS in Rs | 23.38 | 54.00 | 28.34 | 13.01 | 13.22 | 21.93 | 10.12 | 15.40 | 22.87 | 12.75 | 15.52 | 13.16 | 25.62 |
Last Updated: January 1, 2026, 7:37 pm
Below is a detailed analysis of the quarterly data for Expleo Solutions Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Sales, as of Sep 2025, the value is 283.00 Cr.. The value appears strong and on an upward trend. It has increased from 260.00 Cr. (Jun 2025) to 283.00 Cr., marking an increase of 23.00 Cr..
- For Expenses, as of Sep 2025, the value is 236.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 230.00 Cr. (Jun 2025) to 236.00 Cr., marking an increase of 6.00 Cr..
- For Operating Profit, as of Sep 2025, the value is 47.00 Cr.. The value appears strong and on an upward trend. It has increased from 30.00 Cr. (Jun 2025) to 47.00 Cr., marking an increase of 17.00 Cr..
- For OPM %, as of Sep 2025, the value is 17.00%. The value appears strong and on an upward trend. It has increased from 11.00% (Jun 2025) to 17.00%, marking an increase of 6.00%.
- For Other Income, as of Sep 2025, the value is 13.00 Cr.. The value appears strong and on an upward trend. It has increased from 7.00 Cr. (Jun 2025) to 13.00 Cr., marking an increase of 6.00 Cr..
- For Interest, as of Sep 2025, the value is 1.00 Cr.. The value remains steady. There is no change compared to the previous period (Jun 2025) which recorded 1.00 Cr..
- For Depreciation, as of Sep 2025, the value is 7.00 Cr.. The value appears to be improving (decreasing) as expected. It has decreased from 8.00 Cr. (Jun 2025) to 7.00 Cr., marking a decrease of 1.00 Cr..
- For Profit before tax, as of Sep 2025, the value is 51.00 Cr.. The value appears strong and on an upward trend. It has increased from 28.00 Cr. (Jun 2025) to 51.00 Cr., marking an increase of 23.00 Cr..
- For Tax %, as of Sep 2025, the value is 23.00%. The value appears to be improving (decreasing) as expected. It has decreased from 28.00% (Jun 2025) to 23.00%, marking a decrease of 5.00%.
- For Net Profit, as of Sep 2025, the value is 40.00 Cr.. The value appears strong and on an upward trend. It has increased from 20.00 Cr. (Jun 2025) to 40.00 Cr., marking an increase of 20.00 Cr..
- For EPS in Rs, as of Sep 2025, the value is 25.62. The value appears strong and on an upward trend. It has increased from 13.16 (Jun 2025) to 25.62, marking an increase of 12.46.
Overall, while many items appear to show a positive trend, any significant downward movement warrant further investigation.
Profit & Loss - Annual Report
Last Updated: December 15, 2025, 5:23 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 194 | 214 | 264 | 260 | 271 | 283 | 270 | 301 | 743 | 903 | 965 | 1,025 | 1,056 |
| Expenses | 155 | 177 | 210 | 219 | 231 | 230 | 217 | 231 | 618 | 703 | 816 | 859 | 901 |
| Operating Profit | 40 | 37 | 54 | 41 | 40 | 53 | 53 | 70 | 124 | 200 | 149 | 166 | 155 |
| OPM % | 20% | 17% | 20% | 16% | 15% | 19% | 20% | 23% | 17% | 22% | 15% | 16% | 15% |
| Other Income | 10 | 2 | 6 | 1 | 13 | 6 | 8 | 5 | 6 | 16 | 7 | 16 | 27 |
| Interest | 2 | 2 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 2 | 3 | 3 | 3 |
| Depreciation | 6 | 5 | 4 | 5 | 6 | 6 | 6 | 6 | 19 | 28 | 34 | 39 | 36 |
| Profit before tax | 42 | 32 | 56 | 37 | 48 | 54 | 54 | 68 | 110 | 186 | 120 | 139 | 144 |
| Tax % | 29% | 32% | 34% | 36% | 33% | 32% | 26% | 26% | 39% | 28% | 24% | 26% | |
| Net Profit | 30 | 22 | 37 | 24 | 32 | 36 | 40 | 50 | 68 | 134 | 90 | 103 | 104 |
| EPS in Rs | 29.26 | 20.53 | 34.68 | 22.29 | 29.86 | 33.79 | 38.92 | 49.20 | 66.01 | 130.59 | 58.27 | 66.52 | 67.05 |
| Dividend Payout % | 31% | 117% | 69% | 108% | 80% | 0% | 0% | 0% | 0% | 6% | 0% | 75% |
YoY Net Profit Growth
| Year | 2014-2015 | 2015-2016 | 2016-2017 | 2017-2018 | 2018-2019 | 2019-2020 | 2020-2021 | 2021-2022 | 2022-2023 | 2023-2024 | 2024-2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|
| YoY Net Profit Growth (%) | -26.67% | 68.18% | -35.14% | 33.33% | 12.50% | 11.11% | 25.00% | 36.00% | 97.06% | -32.84% | 14.44% |
| Change in YoY Net Profit Growth (%) | 0.00% | 94.85% | -103.32% | 68.47% | -20.83% | -1.39% | 13.89% | 11.00% | 61.06% | -129.89% | 47.28% |
Expleo Solutions Ltd has shown an inconsistent trend in YoY Net Profit Growth (%) in the last 11 years from 2014-2015 to 2024-2025.
Growth
| Compounded Sales Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 31% |
| 3 Years: | 11% |
| TTM: | 4% |
| Compounded Profit Growth | |
|---|---|
| 10 Years: | 17% |
| 5 Years: | 21% |
| 3 Years: | 14% |
| TTM: | 6% |
| Stock Price CAGR | |
|---|---|
| 10 Years: | 5% |
| 5 Years: | 16% |
| 3 Years: | -8% |
| 1 Year: | -22% |
| Return on Equity | |
|---|---|
| 10 Years: | 22% |
| 5 Years: | 21% |
| 3 Years: | 20% |
| Last Year: | 16% |
Last Updated: September 5, 2025, 3:50 am
Balance Sheet
Last Updated: December 4, 2025, 1:13 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | Sep 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 10 | 11 | 11 | 11 | 11 | 11 | 10 | 10 | 16 | 16 | 16 | 16 | 16 |
| Reserves | 98 | 91 | 98 | 116 | 118 | 128 | 142 | 192 | 379 | 515 | 596 | 620 | 688 |
| Borrowings | 12 | 10 | 0 | 0 | 0 | 0 | 0 | 7 | 15 | 26 | 26 | 30 | 20 |
| Other Liabilities | 27 | 54 | 73 | 43 | 63 | 53 | 62 | 56 | 185 | 174 | 128 | 165 | 192 |
| Total Liabilities | 147 | 165 | 182 | 171 | 191 | 192 | 214 | 264 | 594 | 730 | 765 | 831 | 916 |
| Fixed Assets | 27 | 24 | 25 | 27 | 22 | 19 | 26 | 25 | 108 | 142 | 131 | 113 | 91 |
| CWIP | 1 | 1 | 0 | 0 | 0 | 0 | 0 | 0 | 6 | 6 | 5 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 15 | 0 | 0 |
| Other Assets | 119 | 139 | 157 | 144 | 169 | 173 | 188 | 239 | 480 | 582 | 614 | 719 | 825 |
| Total Assets | 147 | 165 | 182 | 171 | 191 | 192 | 214 | 264 | 594 | 730 | 765 | 831 | 916 |
Below is a detailed analysis of the balance sheet data for Expleo Solutions Ltd based on the most recent figures (Sep 2025) and their trends compared to the previous period:
- For Equity Capital, as of Sep 2025, the value is 16.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 16.00 Cr..
- For Reserves, as of Sep 2025, the value is 688.00 Cr.. The value appears strong and on an upward trend. It has increased from 620.00 Cr. (Mar 2025) to 688.00 Cr., marking an increase of 68.00 Cr..
- For Borrowings, as of Sep 2025, the value is 20.00 Cr.. The value appears to be improving (decreasing). Additionally, since Reserves exceed Borrowings, this is considered a positive sign. It has decreased from 30.00 Cr. (Mar 2025) to 20.00 Cr., marking a decrease of 10.00 Cr..
- For Other Liabilities, as of Sep 2025, the value is 192.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 165.00 Cr. (Mar 2025) to 192.00 Cr., marking an increase of 27.00 Cr..
- For Total Liabilities, as of Sep 2025, the value is 916.00 Cr.. The value appears to be increasing, which may not be favorable. It has increased from 831.00 Cr. (Mar 2025) to 916.00 Cr., marking an increase of 85.00 Cr..
- For Fixed Assets, as of Sep 2025, the value is 91.00 Cr.. The value appears to be declining and may need further review. It has decreased from 113.00 Cr. (Mar 2025) to 91.00 Cr., marking a decrease of 22.00 Cr..
- For CWIP, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Investments, as of Sep 2025, the value is 0.00 Cr.. The value remains steady. There is no change compared to the previous period (Mar 2025) which recorded 0.00 Cr..
- For Other Assets, as of Sep 2025, the value is 825.00 Cr.. The value appears strong and on an upward trend. It has increased from 719.00 Cr. (Mar 2025) to 825.00 Cr., marking an increase of 106.00 Cr..
- For Total Assets, as of Sep 2025, the value is 916.00 Cr.. The value appears strong and on an upward trend. It has increased from 831.00 Cr. (Mar 2025) to 916.00 Cr., marking an increase of 85.00 Cr..
Notably, the Reserves (688.00 Cr.) exceed the Borrowings (20.00 Cr.), indicating a solid financial buffer.
Overall, while many items appear to show a positive trend, any significant downward movement or items where Borrowings exceed Reserves warrant further investigation.
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 28.00 | 27.00 | 54.00 | 41.00 | 40.00 | 53.00 | 53.00 | 63.00 | 109.00 | 174.00 | 123.00 | 136.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 105 | 97 | 75 | 60 | 92 | 59 | 103 | 74 | 85 | 97 | 94 | 79 |
| Inventory Days | ||||||||||||
| Days Payable | ||||||||||||
| Cash Conversion Cycle | 105 | 97 | 75 | 60 | 92 | 59 | 103 | 74 | 85 | 97 | 94 | 79 |
| Working Capital Days | 68 | 23 | -7 | 8 | 21 | 15 | 50 | 48 | 46 | 93 | 112 | 67 |
| ROCE % | 40% | 29% | 51% | 31% | 38% | 40% | 38% | 39% | 36% | 39% | 20% | 21% |
Mutual Fund Holdings
| Fund Name | No of Shares | AUM (%) | Amount Invested (Cr) | Previous Number of Shares | Previous Date | Percentage Change |
|---|---|---|---|---|---|---|
| Invesco India Multicap Fund | 133,972 | 0.66 | 17.73 | 133,972 | 2025-04-22 15:56:58 | 0% |
| Invesco India Smallcap Fund | 127,985 | 0.59 | 16.93 | 127,985 | 2025-04-22 15:56:58 | 0% |
Key Financial Ratios
| Month | Mar 25 | Mar 24 | Mar 23 | Mar 22 | Mar 21 |
|---|---|---|---|---|---|
| FaceValue | 10.00 | 10.00 | 10.00 | 10.00 | 10.00 |
| Basic EPS (Rs.) | 66.52 | 58.27 | 86.27 | 52.58 | 49.20 |
| Diluted EPS (Rs.) | 66.52 | 58.27 | 86.27 | 52.58 | 49.20 |
| Cash EPS (Rs.) | 91.85 | 79.96 | 157.79 | 60.32 | 54.86 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 409.69 | 393.78 | 512.06 | 248.93 | 196.90 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 409.69 | 393.78 | 512.06 | 248.93 | 196.90 |
| Revenue From Operations / Share (Rs.) | 660.31 | 621.69 | 881.09 | 394.57 | 293.50 |
| PBDIT / Share (Rs.) | 117.18 | 100.42 | 210.93 | 78.85 | 73.42 |
| PBIT / Share (Rs.) | 91.86 | 78.73 | 183.73 | 71.11 | 67.75 |
| PBT / Share (Rs.) | 89.72 | 77.05 | 181.53 | 70.37 | 66.72 |
| Net Profit / Share (Rs.) | 66.52 | 58.27 | 130.60 | 52.58 | 49.20 |
| NP After MI And SOA / Share (Rs.) | 66.52 | 58.27 | 130.60 | 52.58 | 49.20 |
| PBDIT Margin (%) | 17.74 | 16.15 | 23.93 | 19.98 | 25.01 |
| PBIT Margin (%) | 13.91 | 12.66 | 20.85 | 18.02 | 23.08 |
| PBT Margin (%) | 13.58 | 12.39 | 20.60 | 17.83 | 22.73 |
| Net Profit Margin (%) | 10.07 | 9.37 | 14.82 | 13.32 | 16.76 |
| NP After MI And SOA Margin (%) | 10.07 | 9.37 | 14.82 | 13.32 | 16.76 |
| Return on Networth / Equity (%) | 16.23 | 14.79 | 25.50 | 21.12 | 24.98 |
| Return on Capital Employeed (%) | 20.76 | 18.48 | 33.48 | 27.11 | 33.16 |
| Return On Assets (%) | 12.42 | 11.82 | 18.33 | 15.65 | 19.08 |
| Asset Turnover Ratio (%) | 1.28 | 1.29 | 1.84 | 1.46 | 1.36 |
| Current Ratio (X) | 3.90 | 5.77 | 3.30 | 3.84 | 4.11 |
| Quick Ratio (X) | 3.90 | 5.77 | 3.30 | 3.84 | 4.11 |
| Dividend Payout Ratio (NP) (%) | 75.16 | 8.58 | 0.00 | 0.00 | 0.00 |
| Dividend Payout Ratio (CP) (%) | 54.43 | 6.25 | 0.00 | 0.00 | 0.00 |
| Earning Retention Ratio (%) | 24.84 | 91.42 | 0.00 | 0.00 | 0.00 |
| Cash Earning Retention Ratio (%) | 45.57 | 93.75 | 0.00 | 0.00 | 0.00 |
| Interest Coverage Ratio (X) | 54.75 | 59.74 | 95.85 | 106.51 | 71.28 |
| Interest Coverage Ratio (Post Tax) (X) | 32.08 | 35.66 | 60.35 | 72.02 | 48.77 |
| Enterprise Value (Cr.) | 1006.97 | 1697.97 | 1111.70 | 1571.40 | 398.52 |
| EV / Net Operating Revenue (X) | 0.98 | 1.76 | 1.23 | 3.88 | 1.32 |
| EV / EBITDA (X) | 5.54 | 10.89 | 5.14 | 19.44 | 5.29 |
| MarketCap / Net Operating Revenue (X) | 1.21 | 1.95 | 1.40 | 4.27 | 1.76 |
| Retention Ratios (%) | 24.83 | 91.41 | 0.00 | 0.00 | 0.00 |
| Price / BV (X) | 1.94 | 3.08 | 2.41 | 6.77 | 2.62 |
| Price / Net Operating Revenue (X) | 1.21 | 1.95 | 1.40 | 4.27 | 1.76 |
| EarningsYield | 0.08 | 0.04 | 0.10 | 0.03 | 0.09 |
After reviewing the key financial ratios for Expleo Solutions Ltd, here is a detailed analysis based on the latest available data and recent trends:
- For FaceValue, as of Mar 25, the value is 10.00. This value is within the healthy range. There is no change compared to the previous period (Mar 24) which recorded 10.00.
- For Basic EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For Diluted EPS (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For Cash EPS (Rs.), as of Mar 25, the value is 91.85. This value is within the healthy range. It has increased from 79.96 (Mar 24) to 91.85, marking an increase of 11.89.
- For Book Value[Excl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
- For Book Value[Incl.RevalReserv]/Share (Rs.), as of Mar 25, the value is 409.69. It has increased from 393.78 (Mar 24) to 409.69, marking an increase of 15.91.
- For Revenue From Operations / Share (Rs.), as of Mar 25, the value is 660.31. It has increased from 621.69 (Mar 24) to 660.31, marking an increase of 38.62.
- For PBDIT / Share (Rs.), as of Mar 25, the value is 117.18. This value is within the healthy range. It has increased from 100.42 (Mar 24) to 117.18, marking an increase of 16.76.
- For PBIT / Share (Rs.), as of Mar 25, the value is 91.86. This value is within the healthy range. It has increased from 78.73 (Mar 24) to 91.86, marking an increase of 13.13.
- For PBT / Share (Rs.), as of Mar 25, the value is 89.72. This value is within the healthy range. It has increased from 77.05 (Mar 24) to 89.72, marking an increase of 12.67.
- For Net Profit / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For NP After MI And SOA / Share (Rs.), as of Mar 25, the value is 66.52. This value is within the healthy range. It has increased from 58.27 (Mar 24) to 66.52, marking an increase of 8.25.
- For PBDIT Margin (%), as of Mar 25, the value is 17.74. This value is within the healthy range. It has increased from 16.15 (Mar 24) to 17.74, marking an increase of 1.59.
- For PBIT Margin (%), as of Mar 25, the value is 13.91. This value is within the healthy range. It has increased from 12.66 (Mar 24) to 13.91, marking an increase of 1.25.
- For PBT Margin (%), as of Mar 25, the value is 13.58. This value is within the healthy range. It has increased from 12.39 (Mar 24) to 13.58, marking an increase of 1.19.
- For Net Profit Margin (%), as of Mar 25, the value is 10.07. This value exceeds the healthy maximum of 10. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
- For NP After MI And SOA Margin (%), as of Mar 25, the value is 10.07. This value is within the healthy range. It has increased from 9.37 (Mar 24) to 10.07, marking an increase of 0.70.
- For Return on Networth / Equity (%), as of Mar 25, the value is 16.23. This value is within the healthy range. It has increased from 14.79 (Mar 24) to 16.23, marking an increase of 1.44.
- For Return on Capital Employeed (%), as of Mar 25, the value is 20.76. This value is within the healthy range. It has increased from 18.48 (Mar 24) to 20.76, marking an increase of 2.28.
- For Return On Assets (%), as of Mar 25, the value is 12.42. This value is within the healthy range. It has increased from 11.82 (Mar 24) to 12.42, marking an increase of 0.60.
- For Asset Turnover Ratio (%), as of Mar 25, the value is 1.28. It has decreased from 1.29 (Mar 24) to 1.28, marking a decrease of 0.01.
- For Current Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 3. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
- For Quick Ratio (X), as of Mar 25, the value is 3.90. This value exceeds the healthy maximum of 2. It has decreased from 5.77 (Mar 24) to 3.90, marking a decrease of 1.87.
- For Dividend Payout Ratio (NP) (%), as of Mar 25, the value is 75.16. This value exceeds the healthy maximum of 50. It has increased from 8.58 (Mar 24) to 75.16, marking an increase of 66.58.
- For Dividend Payout Ratio (CP) (%), as of Mar 25, the value is 54.43. This value exceeds the healthy maximum of 50. It has increased from 6.25 (Mar 24) to 54.43, marking an increase of 48.18.
- For Earning Retention Ratio (%), as of Mar 25, the value is 24.84. This value is below the healthy minimum of 40. It has decreased from 91.42 (Mar 24) to 24.84, marking a decrease of 66.58.
- For Cash Earning Retention Ratio (%), as of Mar 25, the value is 45.57. This value is within the healthy range. It has decreased from 93.75 (Mar 24) to 45.57, marking a decrease of 48.18.
- For Interest Coverage Ratio (X), as of Mar 25, the value is 54.75. This value is within the healthy range. It has decreased from 59.74 (Mar 24) to 54.75, marking a decrease of 4.99.
- For Interest Coverage Ratio (Post Tax) (X), as of Mar 25, the value is 32.08. This value is within the healthy range. It has decreased from 35.66 (Mar 24) to 32.08, marking a decrease of 3.58.
- For Enterprise Value (Cr.), as of Mar 25, the value is 1,006.97. It has decreased from 1,697.97 (Mar 24) to 1,006.97, marking a decrease of 691.00.
- For EV / Net Operating Revenue (X), as of Mar 25, the value is 0.98. This value is below the healthy minimum of 1. It has decreased from 1.76 (Mar 24) to 0.98, marking a decrease of 0.78.
- For EV / EBITDA (X), as of Mar 25, the value is 5.54. This value is within the healthy range. It has decreased from 10.89 (Mar 24) to 5.54, marking a decrease of 5.35.
- For MarketCap / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
- For Retention Ratios (%), as of Mar 25, the value is 24.83. This value is below the healthy minimum of 30. It has decreased from 91.41 (Mar 24) to 24.83, marking a decrease of 66.58.
- For Price / BV (X), as of Mar 25, the value is 1.94. This value is within the healthy range. It has decreased from 3.08 (Mar 24) to 1.94, marking a decrease of 1.14.
- For Price / Net Operating Revenue (X), as of Mar 25, the value is 1.21. This value is within the healthy range. It has decreased from 1.95 (Mar 24) to 1.21, marking a decrease of 0.74.
- For EarningsYield, as of Mar 25, the value is 0.08. This value is below the healthy minimum of 5. It has increased from 0.04 (Mar 24) to 0.08, marking an increase of 0.04.
Overall, while many metrics show healthy performance, any figures highlighted in red or significant downward trends warrant further investigation.
Strength and Weakness
| Strength | Weakness |
|---|---|
|
|
Stock Analysis
- Considering all of the following key financial indicators, prospective investors are encouraged to conduct thorough research and seek professional guidance before considering any investment in Expleo Solutions Ltd:
- Net Profit Margin: 10.07%
- Net Profit Margin: This metric indicates the percentage of profit a company makes from its total revenue. A higher net profit margin is generally desirable as it reflects better profitability.
- ROCE: 20.76% (Industry Average ROCE: 14.88%)
- ROCE (Return on Capital Employed): ROCE measures a company's profitability and the efficiency with which its capital is employed. A higher ROCE indicates efficient use of capital.
- ROE%: 16.23% (Industry Average ROE: 20.92%)
- ROE (Return on Equity): ROE measures a company's profitability relative to shareholders' equity. A higher ROE indicates efficient use of shareholders' funds.
- Interest Coverage Ratio (Post Tax): 32.08
- Interest Coverage Ratio: The interest coverage ratio measures a company's ability to cover its interest payments on outstanding debt. A ratio greater than 2 is generally considered healthy as it indicates the company can meet its interest obligations comfortably.
- Quick Ratio: 3.9
- Quick Ratio: The quick ratio assesses a company's ability to cover its short-term liabilities with its most liquid assets. A ratio higher than 1 suggests the company can meet its short-term obligations without relying heavily on inventory.
- Stock P/E: 14.2 (Industry average Stock P/E: 83.43)
- Stock P/E (Price-to-Earnings) Ratio: The P/E ratio compares a company's current share price to its earnings per share. A lower P/E ratio relative to industry peers or historical values may indicate that the stock is undervalued.
- Total Debt / Equity: 0
- Total Debt / Equity: This ratio measures a company's financial leverage by comparing its total debt to its total equity. A lower ratio indicates lower financial risk and greater financial stability.
Stock Rating: - Net Profit Margin: 10.07%
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| IT Consulting & Software | 6A, Sixth Floor, Prince Infocity II, Chennai (Madras) Tamil Nadu 600096 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Ralph Franz Gillessen | Chairman & Non-Exe.Director |
| Mr. Phani Tangirala | Managing Director & CEO |
| Mr. Rajesh Krishnamurthy | Non Executive Director |
| Mr. Narayanan Subramaniam | Independent Director |
| Dr. Srivardhini Keshavamurthy Jha | Independent Director |
| Dr. Varadharajan Sridhar | Independent Director |
| Ms. Shalini Kalsi Kamath | Ind. Non-Executive Director |
FAQ
What is the intrinsic value of Expleo Solutions Ltd?
Expleo Solutions Ltd's intrinsic value (as of 17 January 2026) is ₹885.61 which is 7.07% lower the current market price of ₹953.00, indicating overvalued. Calculated using the PE ratio method, this valuation considers the company's ₹1,479 Cr. market cap, FY2025-2026 high/low of ₹1,371/686, reserves of ₹688 Cr, and liabilities of ₹916 Cr.
What is the Market Cap of Expleo Solutions Ltd?
The Market Cap of Expleo Solutions Ltd is 1,479 Cr..
What is the current Stock Price of Expleo Solutions Ltd as on 17 January 2026?
The current stock price of Expleo Solutions Ltd as on 17 January 2026 is ₹953.
What is the High / Low of Expleo Solutions Ltd stocks in FY 2025-2026?
In FY 2025-2026, the High / Low of Expleo Solutions Ltd stocks is ₹1,371/686.
What is the Stock P/E of Expleo Solutions Ltd?
The Stock P/E of Expleo Solutions Ltd is 14.2.
What is the Book Value of Expleo Solutions Ltd?
The Book Value of Expleo Solutions Ltd is 453.
What is the Dividend Yield of Expleo Solutions Ltd?
The Dividend Yield of Expleo Solutions Ltd is 5.25 %.
What is the ROCE of Expleo Solutions Ltd?
The ROCE of Expleo Solutions Ltd is 21.5 %.
What is the ROE of Expleo Solutions Ltd?
The ROE of Expleo Solutions Ltd is 16.3 %.
What is the Face Value of Expleo Solutions Ltd?
The Face Value of Expleo Solutions Ltd is 10.0.